Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators

Authors

  • Naveed Nazir Shah

  • Khurshid Ahmad Dar

  • Syed Quibtiya

  • Bikram Singh Datta

  • Syed Suriya Farooq

  • Mehvish Mushtaq

Keywords:

COVID-19, smoking, mechanical ventilation, hazard analysis and mycobacterium indicus pranii (MIP)

Abstract

Abstract not found

Downloads

How to Cite

Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators. (2022). Global Journal of Medical Research, 22(K2), 67-79. https://medicalresearchjournal.org/index.php/GJMR/article/view/102185

References

Camilla Mattiuzzi, Giuseppe Lippi (2020) Which lessons shall we learn from the 2019 novel coronavirus outbreak?. 8(3), 48-48.

P Tonnesen, J Marott, B Nordestgaard, S Bojesen, P Lange (2019) Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study. 17, 72.

C Vardavas, K Nikitara (2020) COVID-19 and smoking: a systematic review of the evidence. 18, 20.

Y Wan, J Shang, R Graham, R Baric, F Li (2020) Receptor recognition by novel coronavirus from wuhan: an analysis based on decade-long structural studies of sars.

Joshua Oakes, Robert Fuchs, Jason Gardner, Eric Lazartigues, Xinping Yue (2018) Nicotine and the renin-angiotensin system. 315(5), R895-R906.

Wei-Jie Guan, Zheng-Yi Ni, Yu Hu, Wen-Hua Liang, Chun-Quan Ou, Jian-Xing He, Lei Liu, Hong Shan, Chun-Liang Lei, David Hui, Bin Du, Lan-Juan Li, Guang Zeng, Kwok-Yung Yuen, Ru-Chong Chen, Chun-Li Tang, Tao Wang, Ping-Yan Chen, Jie Xiang, Shi-Yue Li, Jin-Lin Wang, Zi-Jing Liang, Yi-Xiang Peng, Li Wei, Yong Liu, Ya-Hua Hu, Peng Peng, Jian-Ming Wang, Ji-Yang Liu, Zhong Chen, Gang Li, Zhi-Jian Zheng, Shao-Qin Qiu, Jie Luo, Chang-Jiang Ye, Shao-Yong Zhu, Nan-Shan Zhong (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. 382(18), 1708-1720.

Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu, Zhenshun Cheng, Ting Yu, Jiaan Xia, Yuan Wei, Wenjuan Wu, Xuelei Xie, Wen Yin, Hui Li, Min Liu, Yan Xiao, Hong Gao, Li Guo, Jungang Xie, Guangfa Wang, Rongmeng Jiang, Zhancheng Gao, Qi Jin, Jianwei Wang, Bin Cao (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 395(10223), 497-506.

Wei Liu, Zhao-Wu Tao, Lei Wang, Ming-Li Yuan, Kui Liu, Ling Zhou, Shuang Wei, Yan Deng, Jing Liu, Hui-Guo Liu, Ming Yang, Yi Hu (2020) Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. 133(9), 1032-1038.

Xiaobo Yang, Yuan Yu, Jiqian Xu, Huaqing Shu, Jia'an Xia, Hong Liu, Yongran Wu, Lu Zhang, Zhui Yu, Minghao Fang, Ting Yu, Yaxin Wang, Shangwen Pan, Xiaojing Zou, Shiying Yuan, You Shang (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. 8(5), 475-481.

Jin-Jin Zhang, Xiang Dong, Yi-Yuan Cao, Ya-Dong Yuan, Yi-Bin Yang, You-Qin Yan, Cezmi Akdis, Ya-Dong Gao (2020) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. 75(7), 1730-1741.

Janice Leung, Chen Yang, Anthony Tam, Tawimas Shaipanich, Tillie-Louise Hackett, Gurpreet Singhera, Delbert Dorscheid, Don Sin (2020) ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. 55(5), 2000688.

G Gorini, L Clancy, E Fernandez, S Gallus (2020) Smoking history is an important risk factor for severe COVID-19.

Giuseppe Lippi, Brandon Henry (2020) Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). 75, 107-108.

Yushun Wan, Jian Shang, Rachel Graham, Ralph Baric, Fang Li (2020) Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. 94(7), 127-147.

Who (2020) Ogmore, 3rd Baron, (Morgan Rees-Williams) (19 Dec. 1937-2 May 2020).

(2020) Updated rapid risk assessment from ECDC on coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK. 25(12).

Samuel Brake, Kathryn Barnsley, Wenying Lu, Kielan Mcalinden, Mathew Eapen, Sukhwinder Sohal (2020) Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). 9(3), 841.

Hisashi Kai, Mamiko Kai (2020) Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. 43(7), 648-654.

Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Juan Virizuela Echaburu, Maite Antonio, Carme Font, Mercè Biosca, Avinash Ramchandani, Jerónimo Martínez, Jorge Hernando Cubero, Javier Espinosa, Eva Martínez De Castro, Ismael Ghanem, Carmen Beato, Ana Blasco, Marcelo Garrido, Yaiza Bonilla, Rebeca Mondéjar, María Arcusa Lanza, Isabel Aragón Manrique, Aránzazu Manzano, Elena Sevillano, Eduardo Castañón, Mercé Cardona, Elena Gallardo Martín, Quionia Pérez Armillas, Fernando Sánchez Lasheras, Francisco Ayala De La Peña (2015) Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study. 33(5), 465-471.

Joan Smith, Erin Sausville, Vishruth Girish, Monet Yuan, Kristen John, Jason Sheltzer (2020) Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract.

Christopher Petrilli, Simon Jones, Jie Yang, Harish Rajagopalan, Luke O'donnell, Yelena Chernyak, Katie Tobin, Robert Cerfolio, Fritz Francois, Leora Horwitz (2020) Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City.

F Sanchis-Gomar, C Lavie, C Perez-Quilis, B Henry, G Lippi (2020) Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. 95(6), 1222-1230.

Vanessa Monteil, Hyesoo Kwon, Patricia Prado, Astrid Hagelkrüys, Reiner Wimmer, Martin Stahl, Alexandra Leopoldi, Elena Garreta, Carmen Hurtado Del Pozo, Felipe Prosper, Juan Romero, Gerald Wirnsberger, Haibo Zhang, Arthur Slutsky, Ryan Conder, Nuria Montserrat, Ali Mirazimi, Josef Penninger (2020) Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. 181(4), 905-913.e7.

R Patanavanich, S Glantz (2020) Smoking is associated with COVID-19 progression: a meta-analysis. 22(9), 1653-1656.

China Cdc Weekly (2020) The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. 2(8), 113-122.

M Parascandola, L Xiao (2019) Tobacco and the lung cancer epidemic in China. 8, 21-30.

Xiaoling Xu, Mingfeng Han, Tiantian Li, Wei Sun, Dongsheng Wang, Binqing Fu, Yonggang Zhou, Xiaohu Zheng, Yun Yang, Xiuyong Li, Xiaohua Zhang, Aijun Pan, Haiming Wei (2020) Effective treatment of severe COVID-19 patients with tocilizumab. 117(20), 10970-10975.

Jing Liu, Sumeng Li, Jia Liu, Boyun Liang, Xiaobei Wang, Hua Wang, Wei Li, Qiaoxia Tong, Jianhua Yi, Lei Zhao, Lijuan Xiong, Chunxia Guo, Jin Tian, Jinzhuo Luo, Jinghong Yao, Ran Pang, Hui Shen, Cheng Peng, Ting Liu, Qian Zhang, Jun Wu, Ling Xu, Sihong Lu, Baoju Wang, Zhihong Weng, Chunrong Han, Huabing Zhu, Ruxia Zhou, Helong Zhou, Xiliu Chen, Pian Ye, Bin Zhu, Lu Wang, Wenqing Zhou, Shengsong He, Yongwen He, Shenghua Jie, Ping Wei, Jianao Zhang, Yinping Lu, Weixian Wang, Li Zhang, Ling Li, Fengqin Zhou, Jun Wang, Ulf Dittmer, Mengji Lu, Yu Hu, Dongliang Yang, Xin Zheng (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. 55, 102763.

G Gritti (2020) Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support.

Heidi Ledford (2020) Coronavirus breakthrough: dexamethasone is first drug shown to save lives. 582(7813), 469-469.

Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators

Published

2022-05-20

How to Cite

Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators. (2022). Global Journal of Medical Research, 22(K2), 67-79. https://medicalresearchjournal.org/index.php/GJMR/article/view/102185